Combination therapies for treating hematologic malignancies using pyridopyrimidinone inhibitors of pi3k / mtor with bendamustine and / or rituximab.
PK201200379A0Undetermined Publication Date: 2012-07-11EXELIXIS INC +1
Patent Information
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- EXELIXIS INC
- Filing Date
- 2012-06-14
- Publication Date
- 2012-07-11
Need to check novelty before this filing date? Find Prior Art
No text content released.